“VCP dysfunction is linked to neurodegenerative disorders, such as Alzheimer’s,” says first author Lauren Vostal, a graduate ...

Biopharmaceutical company Boehringer Ingelheim is using data and more to drive organizational change and has outlined four ...

In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head ...

Global pharmaceutical company Boehringer Ingelheim Philippines Inc. has given assurance that it is ready to supply the local poultry industry with a vaccine against bird flu as soon as it secures the ...

The global populating is aging, and approximately 29% of people with diabetes worldwide are aged 65 years and older, ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

The Philippine Society of Nephrology (PSN) awarded Boehringer Ingelheim (Philippines), Inc. the prestigious Presidential Service Award during the Annual Convention Opening Ceremony on April 24, 2025, ...

Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...

Healthy cells are constantly breaking down proteins and building up new ones with the help of enzymes aptly named unfoldases, ...